G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 5 I, 1999, Pages 1377-1382

  Karzai, Waheedullah ^a   Von Specht, Bernd Ulrich ^b   Parent, Chantal ^b   Haberstroh, J ^b   Wollersen, Karin ^b   Natanson, Charles ^b   Banks, Steven M ^b   Eichacker, Peter Q ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTIAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD ANALYSIS; BLOOD CULTURE; BODY REGIONS; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ESCHERICHIA COLI; MALE; MORTALITY; NEUTROPHIL; NONHUMAN; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032964088     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.5.9806082     Document Type: Article

References (36)

1. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. 1994, Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771-783.
2. Zeni, F., B. Freeman, and C. Natanson. 1997. Anti-inflammatory therapics to treat sepsis and septic shock: a reassessment. Crit. Care Med. 25:1095-1100.
3. Dale, D. C., W. C. Liles, W. R. Summer, and S. Nelson. 1995. Review: Granulocyte colony-stimulating factor: role and relationships in infectious diseases. J. Infect. Dis. 172:1061-1075.
4. Etchacker, P. Q., Y. Waisman, C. Nalanson, A. Farese, W. D. Hoffman, S. M. Banks, and T. J. MacVittie. 1994. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J. Appl. Physiol. 77:2366-2373.
5. Freeman, B. D., Z. Quezado, F. Zeni, C. Natanson, R. L. Danner, S. M. Banks, M. Quezado, Y. Fitz., J. Bacher, and P. Q. Eichacker. 1997. rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J. Appl. Physiol. 83:1467.
6. Lundblad, R., J. M. Nesland, and K. E. Giercksky. 1996. Granulocyte colony-stimulating factor improves survival rates and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit. Care Med. 24: 820-826.
7. Nelson, S., S. Farkas, N. Fotheringham, H. Ho., T. Marrie, and H. Movahhed. 1996. Filgrastim in the treatment of hospitalized patients with community acquired pneumonia (CAP) (abstract). Am. J. Respir. Crit. Care Med. 151:A535.
8. Wunderink, R. G., K. V. Leeper, R. M. H. Schein, S. Nelson, B. DeBoisblanc, F. Baker, N. Fotheringham, and E. Logann. 1996, Clinical response to figrastim in pneumonia with severe sepsis (abstract). Am. J. Respir. Crit. Care Med. 153: A123.
9. Heard, S., M. I. Fink, R. E. Gamelli, J. S. Solomkin, M. Joshi, A. L. Trask, T. C. Fabian, L. D. Hudson, K. B. Gerold, and E. D. Logan. 1998. The effect of prophylactic administration of recombinant human G-CSF on the incidence of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. Crit. Care Med. 26:748-754.
10. Densen, P., and G. L. Mandell. 1990, Granulocytic phagocytes. In G. L. Mandell, R. G. Douglas, and J. E. Bennett, editors. Principles and Practices of Infectious Diseases, 3rd ed. Churchill Livingstone, New York. 81-101.
11. Lehrer, R., T. Ganz, M. E. Selsled, B. M. Babior, and J. R. Curnutte. 1988. Neutrophils and host defense. Ann. Intern. Med. 109:127-142.
12. Endo, S., K. Inada, Y. Inoue, Y. Yamada, T. Takakuwa, T. Kasai, H. Nakae, Y. Kuwata, S. Hoshi, and M. Yashida. 1991. Evaluation of recombinant granulocyte colony stimulating factor (rhG-CSF) therapy in granulopoietic patients with sepsis. Curr. Med. Res. Opin. 13:233-241.
13. Zimmerman, J. J., and T. V. Ringer. 1992. Inflammatory host responses in sepsis. Crit. Care Clin. 8:163-189.
14. Witthaut, R., A. Farhood, C. W. Smith, and H. Jaeschke. 1994. Complement and tumor necrosis factor-alpha contribute to MAC-1 (CD11b/ 18) up-regulation and systemic neutrophil activation during endoloxemia in vivo. J. Leukoc. Biol. 55:105-111.
15. Albelda, S. M., C. W. Smith, and P. A. Ward. 1994. Adhesion molecules and inflammatory injury. FASEB J. 8:504-512.
16. Heflin, A. C., Jr., and K. L. Brigham. 1981. Prevention by granulocytc depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68:1253-1260.
17. Bersten, A., and W. J. Sibbald. 1989. Acute lung injury in septic shock. Crit. Care Clin. 5:49-77.
18. Repine, J. E., and C. J. Bechler. 1991. Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991. Am. Rev, Respir. Dis, 144:251-252.
19. Wright, S. D., R. A. Ramos, A. Hermanowska-Vosatka, P. Rockwell, and P. A. Detmers, 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281-1286.
20. Mur, E., A. Zabernigg, W. Hibe, W. Eisterer, W. Halder, and J. Thaler. 1997. Oxidative burst of neutrophils in patients with rheumatoid arthritis: influence of various cytokines and medication. Clin. Exp. Rheumatol. 15:233-237.
21. Wilschke, C., M. Krainer, M. Nanut, A. Wagner, W. Linkesch, and C. C. Zielinski. 1995. In viva administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increase neutrophil oxidative burst activity. J. Interferon Cytokine Res. 15:249-253.
22. Yagisawa, M., A. Yuo, S. Kitagawa, Y. Yazaki, A. Togawa, and F. Takaku. 1995. Stimulation and priming of human neutrophils by IL-1 alpha and IL-1 beta: complete inhibition by IL-1 receptor antagonist and no interaction with other cytokines. Exp. Hematol. 23:603-608.
23. Khwaja, A., J. E. Carver, and D. C. Linch. 1992. Interactions of granulocyte-macrophage colony-stimulation factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst, Blood 79:745-753.
24. Yuo, A., S. Kitagawa, T. Kasahara, K. Matsushima, M. Saito, and F. Takaku, 1991. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factor. Blood 78:2708-2714.
25. Freeman, B. D., R. Correa, W. Karzai, C. Natanson, M. Patterson, S. M. Banks, Y. Fitz, R. L. Danner, L. Wilson, and P. Q. Eichacker, 1996. Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J. Appl. Physiol. 80:2066-2076.
26. Eichacker, P. Q., M. J. N. Quezado, F. Zeni, R. Correa, J. Fontana, S. M. Banks, Y. Fitz, R. L. Danner, and C. Natanson. 1996. G-CSF increases or decreases the relative risk of death dependent on site and severity of infection in rats (abstract). Am. J. Respir. Crit. Care Med. 153:A252.
27. Lang, C. H., G. J. Bagby, C. Dobrescu, S. Nelson, and J. J. Spitzer. 1992. Modulation of glucose metabolic response to endotoxin by granulocyte colony-stimulating factor. Am. J. Physiol. 263:RI122-R1129.
28. Terashima, T., M. Kanazawa, K. Sayama, A. Ishizaka, T. Urano, F. Sakamaki, H. Nakamura, and Y. Waki. 1994. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am. J. Respir. Crit. Care Med. 149:1295-1303.
29. Worthen, G. S., C. Haslett, A. J. Rees, R. S. Gumbay, J. E. Henson, and P. M. Henson. 1987. Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am. Rev. Respir. Dis. 136:19-28.
30. Aoki, Y., K. Hiromatsu, N. Kobayashi, T. Hotta, H. Saito, H. Igarashi, Y. Niho, and Y. Yoshikai, 1995. Protective effect of granulocyte colony-stimulating factor against T-cell-mediated lethal shock triggered by superantigen. Blood 86:1420-1427.
31. Buisman, A., J. A. Langermans, and R. Van Furth. 1996. Effect of granulocyte colony-stimulating factor on the course of infection with grampositive bacteria during granulocytopenia induced by lethal irradiation or cyclophosphamide. J. Infect. Dis. 174:417-421.
32. Terashima, T., M. Kanazawa, K. Sayama, et al. 1995. Neutrophil-induced lung protection and injury are dependent on the amount of Pseudomonax aeruginosa administered via airways in guinea pigs. Am. J. Respir. Crit. Care Med. 152:2150-2156.
33. Kanazawa, M., A. Ishizaka, N. Hasegawa, Y. Suzuki, and T. Yokoyama. 1992. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 145:1030 1035.
34. Abraham, E., and P. Stevens. 1992. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia. Crit. Care Med. 20:1127-1138.
35. Nelson, S., W. Summer, G. Bagby, C. Nakamura, L. Stewart, G. Lipscomb, and J, Andresen. 1991. Granulocyte colony-stimulating factor enhances pulmonary host defense in normal and ethanol-treated rats. J. Infect. Dis. 164:901-906.
36. Dunne, J., B. J. Dunkin, S. Nelson, and J. White. 1996. Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis, J. Surg. Res. 61:348-354.